Implication of Protein Kinase A for a Hepato-Protective Mechanism of Milrinone Pretreatment

Journal of Surgical Research

Volumn 155, Issue 1, 2009, Pages 32-39

  Satoh, Kohei ^a   Kume, Makoto ^a   Abe, Yuki ^a   Uchinami, Hiroshi ^a   Yakubouski, Siarhei V ^a,b   Takahashi, Tomokazu ^a   Sato, Tsutomu ^a   Yamamoto, Yuzo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

Author keywords

cAMP dependent protein kinase; phosphodiesterase 3 inhibitor; warm ischemia reperfusion injury of the liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; LACTATE DEHYDROGENASE; MILRINONE; PHOSPHODIESTERASE III; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MECHANISM; ENZYME ACTIVITY; LIVER CONGESTION; LIVER ISCHEMIA; LIVER LEVEL; LIVER NECROSIS; LIVER PROTECTION; MALE; MEAN ARTERIAL PRESSURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULSE RATE; RAT; REPERFUSION INJURY; SURVIVAL RATE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD PRESSURE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HEART RATE; LACTATE DEHYDROGENASES; LIVER; LIVER DISEASES; MALE; MILRINONE; PHOSPHODIESTERASE INHIBITORS; PULSE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349249830     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.004     Document Type: Article

References (26)

1. Kume M., Banafsche R., Yamamoto Y., et al. Dynamic changes of post-ischemic hepatic microcirculation improved by a pretreatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res 136 (2006) 209
2. Boswell-Smith V., Spina D., and Page C.P. Phosphodiesterase inhibitors. Br J Pharmacol 147 (2006) S252
3. Manganiello V.C. Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases. J Mol Cell Cardiol 19 (1987) 1037
4. Watanabe T., Satoo H., Kohara K., et al. Orthovanadate stimulates cAMP phosphodiesterase 3 activity in isolated rat hepatocytes through mitogen-activated protein kinase activation dependent on cAMP-dependent protein kinase. Biol Pharm Bull 27 (2004) 789
5. Suttorp N., Weber U., Welsch T., et al. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest 91 (1993) 1421
6. Feije M.A.H., Ansink K., Vanschoonbeek K., et al. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Biochem Pharmacol 67 (2004) 1559
7. Kopperud R., Krakstad C., Selheim F., et al. cAMP effector mechanisms. Novel twists for an "old" signaling system. FEBS Lett 546 (2003) 121
8. Cullen K.A., McCool J., Anwer M.S., et al. Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 287 (2004) G334
9. Tiwari S., Felekkis K., Moon E.-Y., et al. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 103 (2004) 2661
10. Schoelch C., Kuhlmann J., Gossel M., et al. Characterization of adenosine-A1 receptor-mediated antilipolysis in rats by tissue microdialysis, 1H-spectroscopy, and glucose clamp studies. Diabetes 53 (2004) 1920
11. Gjertsen B.T., Mellgren G., Otten A., et al. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1β action. J Biol Chem 270 (1995) 20599
12. Dostmann W.R.G., Taylor S.S., Genieser H.-G., et al. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem 265 (1990) 10484
13. Yokozaki H., Tortora G., Pepe S., et al. Unhydrolysable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res 52 (1992) 2504
14. Said H.M., Ortiz A., and Ma T.Y. A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: Regulation by a PKA-mediated pathway. Am J Physiol Cell Physiol 285 (2003) C1219
15. Banerjee D.K., Carrasquillo E.A., Hughey P., et al. In vitro phosphorylation by cAMP-dependent protein kinase up-regulates recombinant Saccharomyces cerevisiae mannosylphosphodolichol synthase. J Biol Chem 280 (2005) 4174
16. Arai M., Thurman R.G., and Lemasters J.J. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology 32 (2000) 297
17. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) G15
18. Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290 (2006) G1083
19. Foey A.D., Field S., Ahmed S., et al. Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: Implications for rheumatoid arthritis. Arthritis Res Ther 5 (2003) R317
20. Pradines-Figueres A., and Reatz C.R.H. Processing and secretion of tumor necrosis factor-α in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate. J Biol Chem 267 (1992) 23261
21. Gilles S., Zahler S., Welsch U., et al. Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60 (2003) 608
22. Németh Z.H., Szabó C., Haskó G., et al. Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. Eur J Pharmacol 339 (1997) 215
23. Akbar S., and Minor T. Significance and molecular targets of protein kinase A during cAMP-mediated protection of cold stored liver grafts. Cell Mol Life Sci 58 (2001) 1708
24. Jaeschke H., Gujral J.S., and Bajt M.L. Apoptosis and necrosis in liver disease. Liver Int 24 (2004) 85
25. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: A tale of two deaths?. Hepatology 43 (2006) S31
26. Jaeschke H., and Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125 (2003) 1246